Title | Type | SJR | H index | Total Docs. (2017) | Total Docs. (3years) | Total Refs. (2017) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2017) | %Female (2017) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Perspectives in Medicinal Chemistry | journal | 2.374 Q1 | 17 | 0 | 10 | 0 | 122 | 10 | 5.00 | 0.00 | 0.00 | |
2 | Journal of Psychiatry and Neuroscience | journal | 2.323 Q1 | 114 | 51 | 173 | 2468 | 678 | 141 | 3.89 | 48.39 | 46.91 | |
3 | npj Vaccines | journal | 2.269 Q1 | 47 | 34 | 16 | 1814 | 46 | 15 | 2.88 | 53.35 | 39.78 | |
4 | International Journal of Neuropsychopharmacology | journal | 1.808 Q1 | 125 | 111 | 514 | 6468 | 2277 | 502 | 4.50 | 58.27 | 39.47 | |
5 | Vaccines | journal | 1.691 Q1 | 85 | 51 | 141 | 3816 | 745 | 137 | 5.54 | 74.82 | 43.58 | |
6 | Infection and Drug Resistance | journal | 1.603 Q1 | 65 | 59 | 107 | 2241 | 527 | 105 | 4.13 | 37.98 | 41.43 | |
7 | Frontiers in Pharmacology | journal | 1.587 Q1 | 154 | 939 | 1090 | 58981 | 4637 | 1025 | 3.85 | 62.81 | 44.35 | |
8 | Antimicrobial Resistance and Infection Control | journal | 1.573 Q1 | 66 | 126 | 149 | 4237 | 557 | 145 | 3.75 | 33.63 | 42.62 | |
9 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 1.556 Q1 | 47 | 44 | 106 | 2154 | 415 | 106 | 3.06 | 48.95 | 35.32 | |
10 | Drugs | journal | 1.547 Q1 | 188 | 163 | 472 | 11786 | 2433 | 463 | 5.16 | 72.31 | 37.54 | |
11 | Therapeutic Advances in Drug Safety | journal | 1.494 Q1 | 46 | 35 | 71 | 1424 | 333 | 52 | 2.56 | 40.69 | 43.62 | |
12 | Orphanet Journal of Rare Diseases | journal | 1.413 Q1 | 136 | 187 | 573 | 7778 | 2226 | 567 | 3.83 | 41.59 | 51.53 | |
13 | CNS Neuroscience and Therapeutics | journal | 1.380 Q1 | 91 | 99 | 402 | 4502 | 1306 | 317 | 3.04 | 45.47 | 40.00 | |
14 | Journal of Biomedical Science | journal | 1.302 Q1 | 110 | 95 | 289 | 6787 | 1043 | 289 | 3.55 | 71.44 | 41.67 | |
15 | Trials | journal | 1.291 Q1 | 98 | 612 | 1682 | 23937 | 4021 | 1652 | 2.18 | 39.11 | 46.78 | |
16 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.272 Q1 | 57 | 64 | 175 | 3550 | 510 | 169 | 2.61 | 55.47 | 25.97 | |
17 | PPAR Research | journal | 1.204 Q1 | 59 | 25 | 85 | 1798 | 273 | 83 | 3.46 | 71.92 | 42.19 | |
18 | Molecular Therapy - Oncolytics | journal | 1.193 Q1 | 42 | 34 | 66 | 1695 | 241 | 64 | 3.87 | 49.85 | 39.01 | |
19 | Cancer Chemotherapy and Pharmacology | journal | 1.147 Q1 | 122 | 260 | 841 | 8494 | 2576 | 824 | 2.94 | 32.67 | 31.44 | |
20 | AIDS Reviews | journal | 1.118 Q1 | 62 | 32 | 97 | 1524 | 192 | 73 | 1.88 | 47.63 | 39.39 | |
21 | Vascular Health and Risk Management | journal | 1.096 Q1 | 82 | 53 | 192 | 2325 | 664 | 186 | 3.98 | 43.87 | 33.20 | |
22 | Biologics: Targets and Therapy | journal | 1.084 Q2 | 47 | 13 | 56 | 555 | 193 | 54 | 2.82 | 42.69 | 24.14 | |
23 | Therapeutic Advances in Respiratory Disease | journal | 1.081 Q2 | 50 | 38 | 100 | 1761 | 353 | 93 | 3.74 | 46.34 | 47.16 | |
24 | AIDS Research and Therapy | journal | 1.080 Q2 | 49 | 60 | 124 | 2461 | 304 | 123 | 2.47 | 41.02 | 43.12 | |
25 | Cardiovascular Therapeutics | journal | 1.075 Q2 | 54 | 71 | 154 | 2744 | 394 | 149 | 2.32 | 38.65 | 30.24 | |
26 | Therapeutic Advances in Infectious Disease | journal | 1.065 Q2 | 29 | 15 | 25 | 926 | 138 | 23 | 7.07 | 61.73 | 25.81 | |
27 | Antibiotics | journal | 1.063 Q2 | 77 | 39 | 116 | 2276 | 357 | 112 | 2.84 | 58.36 | 47.03 | |
28 | CPT: Pharmacometrics and Systems Pharmacology | journal | 1.040 Q2 | 55 | 94 | 210 | 3074 | 681 | 205 | 3.24 | 32.70 | 35.28 | |
29 | International Journal of Breast Cancer | journal | 1.025 Q2 | 23 | 17 | 51 | 481 | 124 | 51 | 2.17 | 28.29 | 52.08 | |
30 | Journal of Experimental Pharmacology | journal | 0.981 Q2 | 23 | 9 | 13 | 501 | 27 | 13 | 1.92 | 55.67 | 23.68 | |
31 | Clinical Pharmacology: Advances and Applications | journal | 0.972 Q2 | 34 | 19 | 53 | 708 | 168 | 52 | 2.79 | 37.26 | 37.08 | |
32 | OncoTargets and Therapy | journal | 0.967 Q2 | 86 | 598 | 1459 | 24076 | 4171 | 1450 | 2.81 | 40.26 | 37.29 | |
33 | Infection and Chemotherapy | journal | 0.823 Q2 | 38 | 54 | 146 | 1493 | 257 | 122 | 1.73 | 27.65 | 47.39 | |
34 | BMC pharmacology & toxicology | journal | 0.785 Q2 | 43 | 82 | 180 | 3011 | 437 | 177 | 1.97 | 36.72 | 37.09 | |
35 | Clinical Psychopharmacology and Neuroscience | journal | 0.760 Q2 | 42 | 68 | 158 | 2489 | 327 | 146 | 2.09 | 36.60 | 33.22 | |
36 | Therapeutics and Clinical Risk Management | journal | 0.748 Q2 | 70 | 189 | 532 | 6822 | 1268 | 515 | 2.19 | 36.10 | 37.09 | |
37 | Current Therapeutic Research | journal | 0.717 Q2 | 46 | 26 | 69 | 824 | 175 | 64 | 1.64 | 31.69 | 26.61 | |
38 | European Review for Medical and Pharmacological Sciences | journal | 0.680 Q2 | 88 | 840 | 2107 | 5247 | 3669 | 1981 | 1.84 | 6.25 | 37.58 | |
39 | Drug Metabolism and Pharmacokinetics | journal | 0.652 Q2 | 75 | 44 | 207 | 1791 | 428 | 197 | 2.16 | 40.70 | 30.99 | |
40 | Journal of Anaesthesiology Clinical Pharmacology | journal | 0.612 Q2 | 42 | 142 | 471 | 2337 | 481 | 270 | 0.96 | 16.46 | 39.22 | |
41 | Advances in Pharmacological Sciences | journal | 0.591 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
42 | Therapeutic Advances in Cardiovascular Disease | journal | 0.535 Q2 | 41 | 28 | 107 | 1312 | 163 | 95 | 1.71 | 46.86 | 30.97 | |
43 | Drug Target Insights | journal | 0.529 Q3 | 16 | 3 | 20 | 117 | 46 | 19 | 2.23 | 39.00 | 30.77 | |
44 | Iranian Journal of Pharmaceutical Research | journal | 0.502 Q3 | 58 | 188 | 511 | 6882 | 838 | 497 | 1.46 | 36.61 | 39.66 | |
45 | Journal of Pharmacology and Pharmacotherapeutics | journal | 0.476 Q3 | 42 | 39 | 184 | 816 | 243 | 127 | 1.08 | 20.92 | 32.54 | |
46 | Advances in Clinical and Experimental Medicine | journal | 0.472 | 43 | 197 | 422 | 6093 | 658 | 422 | 1.47 | 30.93 | 51.68 | |
47 | Australian Prescriber | journal | 0.465 Q3 | 40 | 70 | 251 | 1009 | 193 | 104 | 1.00 | 14.41 | 44.44 | |
48 | Indian Journal of Pharmacology | journal | 0.412 Q3 | 68 | 79 | 486 | 1568 | 499 | 420 | 0.90 | 19.85 | 38.43 | |
49 | International Journal of Cancer Management | journal | 0.402 Q3 | 26 | 158 | 189 | 4600 | 221 | 170 | 1.25 | 29.11 | 42.67 | |
50 | Synergy | journal | 0.344 Q3 | 15 | 12 | 26 | 422 | 36 | 24 | 1.38 | 35.17 | 29.55 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®